DRIVE Call for Tenders is now open for sites for studying influenza vaccine effectiveness. The purpose of the call is to support the sharing of existing influenza vaccine effectiveness (IVE) data and to establish new IVE studies able to collect vaccine brand-specific information. The call is open to any European organization, institution or network capable with the required infrastructure. The call closes on the 30th of March 2020.
The Research Collaborator will be compensated by FISABIO (the DRIVE Coordinator) for data sharing and contribution to the analysis, and for its participation in project meetings. The allocated budget will be sized according to the associated workload and consequent contribution to the pooled analysis (in terms of sample size). The terms and conditions of collaboration will be formalized through a Research Agreement between the Research Collaborator and FISABIO (DRIVE Coordinator).
The benefits to the Research Collaborator include:
- Generating robust brand specific IVE through a European network.
- Implementing potentially innovative approaches for brand-specific IVE estimation.
- Participation in the scientific discussion and publications process.
- Receiving funding for data sharing and capacity building.
- Participation in the DRIVE Annual Forum and General Assembly.
Learn more about this news in this link: https://www.drive-eu.org/index.php/2020/02/03/tenders-20202021/